Should MitraClip be preferred over surgery in high-risk patients with severe MR and CKD?
Severe mitral regurgitation (MR) may lead to worsening renal function due to a decrease in stroke volume, increase in systemic vascular resistance, and venous pooling. Percutaneous treatment with MitraClip seems to improve renal function in certain patient groups. Larger studies are needed to prove that MitraClip is the preferred strategy in patients with severe MR and chronic kidney disease.